Cellular Autophagy
Sandoz bets on strong growth in biosimilars market
Sandoz aims to double net sales by 2035 with 100 biosimilars by 2040, capitalizing on patent expirations in the biosimilars market.
By Ava Brown · Sep 8, 2026
Tag: forecast
Cardiovascular Metrics
Isomab Shows Safe Blood Vessel Growth in CAD
Pro angiogenic therapy shows safe blood vessel growth in coronary artery disease, with a systematic review of 11 studies finding no new risks for patients.
By Maya Puspitasari · Aug 29, 2026